Rainbow Scientific and SciGene announced today new partnership whereby customers in North America can now purchase SciGene’s sample preparation reagents from Rainbow Scientific.
Rainbow Scientific, Inc. (Windsor, CT) and SciGene (Sunnyvale, CA) announced today at the Association for Molecular Pathology Annual meeting in Phoenix, AZ , a new partnership whereby customers in North America can now purchase SciGene’s line of sample preparation reagents for FISH-based tests directly from Rainbow Scientific, Inc. Products to be sold under the agreement include: CytoZyme™ Stabilized Pepsin, CytoBond® Removable Coverslip Sealant, FISH slide wash buffers and tissue pretreatment reagents developed and manufactured by SciGene...
TxCell personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today that it received a Manufacturing Accreditation delivered by the French National Agency for Drug Safety (ANSM). The status has been received for its cell therapy production site in Besançon, France...
Malvern Instruments brings a new addition to Pittcon in 2014, exhibiting NanoSight Nanoparticle Tracking Analysis (NTA) systems within its growing portfolio of analytical solutions for industry and academia.
Pittcon 2014 is Malvern’s first major exposition in the US since acquiring NanoSight in September 2013, a move which resulted in the addition of NTA to Malvern’s technologies for particle sizing and counting at the nanoscale. NTA systems will be on show alongside the Zetasizer Nano and the new Viscotek SEC-MALS 20 GPC/SEC detector. Also on the Malvern booth is the Mastersizer 3000 laser diffraction particle size analyzer featuring new software....
A Sonicator system for every application and sample volume
M2 Scientifics is pleased to announce the addition of QSonica Sonicators to their growing list of trusted brands. QSonica has been a leader in the design, development, and manufacturing of ultrasonic liquid processors for more than 40 years. Their products represent some of the most powerful and technologically advanced ultrasonic devices on the market today....
Photon Control Inc. have been listed on Business in Vancouver’s list of B.C’s 100 most profitable companies for the first time achieving the 94th spot.
Photon Control also reached the 20th spot on the Top 50 B.C. Companies with the highest profit margin. Photon Control’s President Christopher Weston says, “I am proud to see Photon Control on B.C.’s Top 100 Profitable and on the Top 50 B.C. Companies with the highest profit margin. These accolades highlight our team’s commitment and technical expertise to build a strong product portfolio with repeated customer satisfaction. We look forward to continuing to grow the Photon Control brand and market presence...
Move Will Prevent Millions of Animals From Having Harsh Chemicals Dripped Into Their Eyes and Rubbed Into Their Skin
After an extensive PETA India campaign, with help from MP Maneka Gandhi and others – the Drugs Technical Advisory Board (DTAB), which operates under the Ministry of Health & Family Welfare, has recommended the addition of a suitable provision under The Drugs and Cosmetics Rules, 1945, to prohibit the import of cosmetics that have been tested on animals abroad. This decision – made in the DTAB's 65th meeting, held on 25 November 2013 – comes on the heels of recently enacted bans on the import, marketing and sale of cosmetics and their ingredients tested on animals in the European Union and Israel as well as a recent decision to eliminate animal tests for cosmetics by the Bureau of Indian Standards, which oversees standards for cosmetics...
Swansea University, College of Medicine, presents scientific poster at IDF 2013
EKF Diagnostics, the global diagnostics business, announces the successful assessment of its Quo-Test and Quo-Lab point-of-care HbA1c analyzers within the College of Medicine, Swansea University. Dr Stephen Luzio, Associate Professor at the University, is giving a scientific poster presentation entitled ‘Assessment of two point-of-care analyzers for the determination of HbA1c’ at the World Diabetes Congress – International Diabetes Federation (IDF) 2013, Melbourne, Australia, 2nd to 6th December...
A north-west leading diagnostic imaging company has merged with a well-known provider of ultrasound services.
The deal between Altrincham-based Diagnostic Healthcare and Chester-based Ultrasound Now will create a major provider of diagnostic services in the North West, Yorkshire, the Midlands and North Wales. The enlarged business will offer an enhanced service in more than 45 clinics across these areas, scanning more than 80,000 ultrasound patients a year. Diagnostic Healthcare operates a network of centres across the UK providing MRI scans, ultrasound, bone density scans (DEXA scan), health screening and reporting services....
Avacta Analytical – a world leader in biophysical analysis of proteins – has established a dedicated European applications support team, enabling customers to harness the Company’s expertise in protein characterisation, analysis and product formulation.
This new service will help to exploit the unique capabilities of the Optim® microvolume protein analysis and characterisation instrument to its full potential, providing unrivalled customer support for a wide range of applications. Optim users across Europe now have the opportunity to work with a customer-focused applications team with exceptional knowledge of the Optim technology and broad practical expertise in developing cutting-edge applications for the instrument. The highly experienced team is perfectly positioned to provide technical information and demonstrations, introductory and indepth training – either on site or via webinars – as well as method development and application support...
The DNA Section of the Orange County Crime Laboratory (OCCL) in California, USA, has recently taken delivery of its first Air LiHa equipped Freedom EVO® workstation for DNA quantitation and amplification reaction set-up.
Complementing the laboratory’s existing liquid displacement Freedom EVO platforms for DNA extraction, this new instrument will help to streamline the workflow and improve pipetting precision. Robert Binz, a Forensic Scientist at OCCL, explained: “We purchased our first Freedom EVO in 2010 to speed up DNA extraction....
PAC, a leading global provider of advanced analytical instruments for laboratories and online process applications, is pleased to announce that Advanced Sensors, a leading global supplier of Oil in Water analyzers, has joined the PAC team.
Advanced Sensors has served oil and gas and marine customers with highly accurate and exceptionally reliable process analyzers since 2006. The Advanced Sensors Oil in Water analyzers operate in harsh environments with zero routine maintenance, consistently providing highly accurate and reliable results....
The young Parisian firm will market its imaging instruments to the life sciences sector within twelve months
Bioaxial, developers of super-resolved fluorescence microscopy for the extended imaging of live cells, today announces the completion of a EUR 1.9million (USD 2.7 million) equity investment by three new large investors; Amorcage Technologique Investissement (a fund managed by CEA Investissement), Inserm Transfert Initiative and Viveris Management plus a range of individual investors...
ZEISS has granted a license for patents relating to LED fluorescence excitation in microscopy to Lumencor, Inc., Beaverton, USA.
These patents protect the use of light emitting diodes for the excitation of fluorescence radiation in light microscopes. The property rights, which are valid in the USA and Canada, were acquired by ZEISS in 2005. ZEISS uses this technology in a number of products such as iLED-module, Axio Scope with integrated LED illumination for fluorescence applications and Colibri.2 for a wide range of applications extending from routine to high-end microscopy....
GSK reports sales growth +1%, earnings per share +16% and strong cash generation which has enabled the company to re-affirm its guidance for the full year.
Simon Dingemans, CFO, gives an update on the emerging markets business. Key highlights: Core EPS 28.9p (+16%) benefiting from operating, financial and long-term cost efficiencies. Pharma & Vaccines sales flat: US +2%, Europe +5%, Japan +2% offset by EMAP -9%. Consumer Healthcare +4%. 4 approvals in 3 markets; Tivicay for HIV and FluLaval Q-IV vaccine for flu; Tafinlar for metastatic melanoma; Relvar Ellipta for asthma..
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.
This investment is a direct response to the rapid rate of adoption of the Company’s Translational Pharmaceutics platform and unique approach by a growing international client base. Translational Pharmaceuticsintegrates formulation development, real-time manufacturing and clinical testing to offer shorter timelines, reduced costs and increased success rates in early phase drug development....
Dynaflow® Resolve Temperature Control combines controlled solution exchange with precise temperature regulation
Cellectricon, a leading provider of advanced cell-based screening technologies and services, launches the Dynaflow® Resolve Temperature Control system at Neuroscience 2013 (San Diego), booth #933. Cellectricon’s Dynaflow Resolve automated perfusion system uses microfluidics for rapid and efficient solution exchange experiments, enabling the measurement of ion channel current regardless of cell type or compound. The new Temperature Control add-on module has been specifically developed to enable high performance patch clamp experiments at physiological temperatures, from room temperature up to 45 °C...
New Eppendorf Microinjection Suite at the Hadyn Ellis building supports researchers in pioneering work
As part of Eppendorf’s commitment to UK Science and to delivering the highest quality instruments and consumables to the life science community, the company has provided Cardiff University’s flagship Hadyn Ellis building, newly opened in November 2013, with a complete microinjection facility. The new Eppendorf Microinjection Suite will support pioneering work in critically important areas such as how recently identified ‘cancer stem cells’ drive the growth of the most common types of cancer, as well as bringing about a better understanding of a range of neurodegenerative disorders...
Laboratory equipment manufacturer and supplier Yorlab is marking a triple celebration as it opens its new North East office in South Hetton, launches its new look and starts to promote its dynamic new website.
Led by Branch Manager Amy Reay, the new office is based on South Hetton Industrial Estate and is designed to serve the company’s growing client base within the North East area. Previously located at Bearpark on the western side of Durham, the new office is based just off the A19 and will provide much improved access to the region’s transport network plus offer more space and facilities for both staff and warehousing...
Graduates from the Centre’s four year PhD programme will lead new industries based on the optimal integration of photonics in electronic systems
UCL and Cambridge University have successfully gained funding for a new Engineering and Physical Sciences Research Council (EPSRC) Centre for Doctoral Training (CDT) in Integrated Photonic and Electronic Systems (IPES). The new Centre builds on the enormous success of the EPSRC funded collaboration between these two world-leading universities who set up a joint CDT for Photonic Systems Development in 2009...
Frost & Sullivan: Healthcare innovation hinges on managing escalating amounts of data priming to more than triple the market
The decreasing cost of genome sequencing lends momentum to the global next-generation sequencing (NGS) informatics market. As affordability drives adoption of genome sequencing in multiple end-user segments, an enormous output of NGS data to store and analyze is an overwhelming result. While primary and secondary data analysis tools are likely to become a commodity as pipelines standardize, the high-value tertiary data analysis segment used for biological interpretation and clinical reporting will drive revenue growth...
Read MoreOncodesign and UCB enter into a research collaboration for the early development of new therapeutic agents in neurodegenerative diseasesDec 17, 2013
The partnership is based on Oncodesign's Nanocyclix(R) technology platform for next generation kinase inhibitors and UCB’s expertise in neurology
Oncodesign, a drug discovery company and oncology pharmacology service provider, announces today that it has entered into a research collaboration and exclusive license option with UCB, a global biopharmaceutical leader specialised in neurology and immunology. The collaboration will leverage the respective expertise of Oncodesign and UCB to bring innovative therapeutic solutions to patients suffering from neurodegenerative disorders....
Pivotal is pleased to announce that it has received French research tax credit approval for years 2013 through 2015.
According to Lidia Farr Corporate Development at Pivotal "We are extremely pleased to receive this approval from the French Ministry of Research since it will provide Pivotal with greater opportunities to support current and future customers in this important European market". The French Ministry of Research (Ministère de l'Enseignement Supérieur et de la Recherche) has granted the French R&D tax credit ("Crédit d'Impôt Recherche", CIR) accreditation to Pivotal as of July 2013...
The deal between Altrincham-based Diagnostic Healthcare and Chester-based Ultrasound Now will create a major provider of diagnostic services in the North West, Yorkshire, the Midlands and North Wales. The enlarged business will offer an enhanced service in more than 45 clinics across these areas, scanning more than 80,000 ultrasound patients a year. Diagnostic Healthcare operates a network of centres across the UK providing MRI scans, ultrasound, bone density scans (DEXA scan), health screening and reporting services....
Complementing the laboratory’s existing liquid displacement Freedom EVO platforms for DNA extraction, this new instrument will help to streamline the workflow and improve pipetting precision. Robert Binz, a Forensic Scientist at OCCL, explained: “We purchased our first Freedom EVO in 2010 to speed up DNA extraction....
Simon Dingemans, CFO, gives an update on the emerging markets business. Key highlights: Core EPS 28.9p (+16%) benefiting from operating, financial and long-term cost efficiencies. Pharma & Vaccines sales flat: US +2%, Europe +5%, Japan +2% offset by EMAP -9%. Consumer Healthcare +4%. 4 approvals in 3 markets; Tivicay for HIV and FluLaval Q-IV vaccine for flu; Tafinlar for metastatic melanoma; Relvar Ellipta for asthma..
Cellectricon, a leading provider of advanced cell-based screening technologies and services, launches the Dynaflow® Resolve Temperature Control system at Neuroscience 2013 (San Diego), booth #933. Cellectricon’s Dynaflow Resolve automated perfusion system uses microfluidics for rapid and efficient solution exchange experiments, enabling the measurement of ion channel current regardless of cell type or compound. The new Temperature Control add-on module has been specifically developed to enable high performance patch clamp experiments at physiological temperatures, from room temperature up to 45 °C...
UCL and Cambridge University have successfully gained funding for a new Engineering and Physical Sciences Research Council (EPSRC) Centre for Doctoral Training (CDT) in Integrated Photonic and Electronic Systems (IPES). The new Centre builds on the enormous success of the EPSRC funded collaboration between these two world-leading universities who set up a joint CDT for Photonic Systems Development in 2009...
According to Lidia Farr Corporate Development at Pivotal "We are extremely pleased to receive this approval from the French Ministry of Research since it will provide Pivotal with greater opportunities to support current and future customers in this important European market". The French Ministry of Research (Ministère de l'Enseignement Supérieur et de la Recherche) has granted the French R&D tax credit ("Crédit d'Impôt Recherche", CIR) accreditation to Pivotal as of July 2013...